Dyne Therapeutics, Inc.
DYN
$9.57
-$0.48-4.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.83% | 7.81% | -49.19% | 0.83% | 1.48% |
| Total Depreciation and Amortization | 11.56% | 2.74% | 9.77% | 3.37% | -3.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.70% | 24.91% | 40.90% | -71.40% | 242.81% |
| Change in Net Operating Assets | 29.16% | -135.86% | 234.17% | 112.92% | -228.59% |
| Cash from Operations | -25.56% | -13.01% | -36.02% | 30.14% | -124.35% |
| Capital Expenditure | 8.74% | -324.90% | 70.48% | -348.69% | -132.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.33% | 22.01% | -259.17% | 106.70% | -783.64% |
| Cash from Investing | 109.11% | 17.49% | -273.64% | 106.21% | -786.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,784.52% | -79.81% | -95.26% | -6.99% | 277,714.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,784.52% | -79.81% | -95.26% | -6.99% | 277,714.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.06% | -27.21% | -122.61% | 124.09% | 1,831.66% |